Guizhou Xinbang Pharmaceutical Co., Ltd. Stock: price and insider trades · China
信邦制药
No insider purchase over the last 90 days. The latest, by 高文林, was filed 23 May 2022.
Guizhou Xinbang Pharmaceutical Co., Ltd.: what insiders have been doing
Every trade that managers of Guizhou Xinbang Pharmaceutical Co., Ltd. disclose to SSE / SZSE (CSRC) is tracked on this page. The company sits in the Health Care sector. Nothing new has been filed by managers of Guizhou Xinbang Pharmaceutical Co., Ltd. in twelve months, the latest record being from 23 May 2022.
Looking back to 2022, when coverage begins, insiders filed 2 purchases and no sales.
In the same sector, recent insider purchases at Dynavox Group AB and Vetoquinol SA also feature in our signals. Every figure here comes from the filings published by SSE / SZSE (CSRC) and describes the past, not future prices; it is not investment advice.
Since the insiders bought
- +1.1%Entry CN¥4.63 · Close at T+365 CN¥4.68
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2024FY ended December 2024 · cache
About Guizhou Xinbang Pharmaceutical Co., Ltd.
信邦制药 is a company specializing in the health and pharmaceutical sector, providing innovative pharmaceutical products. It is listed on the XSHE market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
